From Stanford-UCSF Health Services (E.V.P.) and Stanford University
School of Medicine (Y.K., P.J.F., W.J.S., E.L.A., S.N.O., P.G.Y., S.H.S.),
Stanford, Calif, and the Heart Center Siegburg, Siegburg, Germany (E.G.).
Correspondence to Simon H. Stertzer, MD, Professor of Medicine, Division of Cardiovascular Medicine, Stanford University School of Medicine, 300 Pasteur Dr, Room H2103, Stanford, CA 94305. E-mail simon_stertzer{at}cvmed.stanford.edu
Methods and ResultsWe deployed 3.0- and 4.0-mm Palmaz-Schatz,
Wiktor, Multilink, NIR, and InStent stents in precision-cast phantoms.
Central lumens of 2.0 mm were created. There was no difference
between the "true" diameters of any stented lumen by both QCA and
quantitative ultrasonic (QCU) measurement poststenting. QCA systematic
error (SE) varied from 0.01 for the Wiktor stents to 0.14 mm for
the Palmaz-Schatz stents; the random error (RE) was 0.03 to 0.14
mm. QCU SE varied from 0.05 to 0.11 mm, and RE ranged from 0.01 to
0.07 mm. At the next stage, 4.0-mm Wiktor and Palmaz-Schatz stents
were deployed into the phantom lumens; 1.5-, 2.0-, 2.5- and 3.0-mm
lumens were created inside the stents. QCA and QCU measurements of 1.5-
to 2.5-mm residual lumens were overestimated by 0.1 to 0.3 mm. In
the 3.0-mm residual lumen within the Wiktor stent, QCA underestimated
the luminal size by -0.1 mm. There was no QCA inaccuracy for a
3.0-mm lumen within the Palmaz-Schatz stent. In patients, in 25 stented
segments in both the Palmaz-Schatz and Wiktor groups, there was no
difference between QCA and QCU diameters.
ConclusionsQCU is sufficiently precise for the assessment of the
coronary lumen after stenting. QCA can be used as an accurate
method of poststent assessment, except when a very mild
recurrence within a highly opaque stent is measured. In that
instance, QCA may underestimate the luminal diameter.
To facilitate a combined approach to coronary quantification
with both ultrasound and angiography, the present study was
designed to address the validity of QCA and QCU for the measurement of
phantom lumens stented with different stent models with and without
simulated in-stent recurrence. In addition, a clinical
comparison between QCA and QCU is reported.
We deployed 3.0- and 4.0-mm J&J PS, Medtronic Wiktor, ACS
Multilink, Boston Scientific NIR, and Medtronic InStent into 5 separate
lumens. The sixth lumen was kept unstented to serve as control.
Immediately after deployment, inflation to 16 atm was performed to
achieve adequate stent apposition. To assess the results after
deployment, the phantoms were filled with Omnipaque 350 mg/mL and
imaged on 35-mm cinefilm with a Philips Integris system. Body density
was simulated with a copper phantom. A Namic 10-mm area determination
grid was placed under the phantom for calibration. QCA was performed
off-line using a computerized edge detection program (QCA Plus, Sanders
Data System), developed and validated at
Stanford.6 7 8 QCA measurements included minimum
luminal diameter, reference diameter, and average diameter. The same
set of measurements was repeated at a nonstented part of the channel.
All measurements were performed in triplicate.
IVUS pullback was performed after that by use of a ClearView
Ultra unit (Boston Scientific Corp) with 2.9F MicroView 30-MHz
coronary imaging catheter (Cardiovascular
Imaging Systems). Images were recorded during slow pullback of the
catheter. QCU was performed with TapeMeasure (INDEC Systems, Inc).
Luminal area, minimum and maximum diameters, and average diameters were
obtained. All measurements were performed in triplicate.
Phantom Stage 2: Moderate Poststent Restenosis
Model
Phantom Stage 3: Critical Poststent Restenosis Model
Systematic error (accuracy)9 of the method was
calculated as the average difference between "true" and measured
values. Random error (precision) was calculated as the SD of these
differences.
Patient Studies
Statistical Analysis
Phantom Stage 2: Moderate Poststent Restenosis Model
Phantom Stage 3: Critical Poststent Restenosis Model
In the Wiktor stent, for a 3.0-mm residual lumen, QCU gave practically
perfect luminal estimates, whereas QCA measurements slightly
underestimated luminal size (-0.1 mm). There was no statistical
difference between QCA or QCU measurements and true lumen size for both
stents.
Patient Study
The fact that QCU diameter of control lumens was slightly larger than
that of QCA and larger than the "true" lumen is probably related to
the fact that IVUS was not designed to image lumens in a block of
casting resin. The properties of casting resin differ considerably from
the blood vessels. It is important that immediately after deployment,
QCA and QCU accuracy and precision did not differ between control and
any stented lumen.
The moderate poststent restenosis models (phantom stage 2) were
more complex than phantom stage 1 models. Except for PS stents,
systematic and random QCA errors were the same for these models. QCU
systematic error was somewhat smaller for the control lumen.
Nevertheless, overall systematic and random error values for QCU and
QCA were acceptable, ie, comparable to that reported for other nonstent
QCA and QCU validation studies.10 11 12 13 The QCA
Plus system used at Stanford allows the operator to specify the search
path along both sides of the vessel before the automatic edge detection
algorithm is applied. Consequently, compared with
path-line14 systems like
CAAS15 or CMS,16 QCA Plus
provides better poststent edge definition (Figure 9
The critical poststent restenosis models (phantom stage 3) with
both the highly opaque Wiktor stent and the minimally opaque PS stent,
along with decreasing diameter of residual lumen, demonstrated
excellent reproducibility between QCA and QCU and acceptable levels of
systematic and random errors. There was no difference between QCA or
QCU and true diameter estimates. Figure 4
The patient study part of our study confirms that immediately after
stenting in vivo, there is no difference between QCA and QCU intrastent
lumen estimates, despite the difference in x-ray opacity. The absence
of difference was substantiated with the nonpaired t test.
With paired t test applied, however, the difference between
QCU and QCA measurements of both PS and Wiktor was significant
(P<0.01). We believe, however, that the paired statistic is
not applicable here because of the remaining differences in the
location of the QCA and QCU determinations and in measurements during
different phases of the cardiac cycle.
We also observed a close linear relationship between QCA and QCU
measurements. The significant difference in the reference lumen size
(QCU estimate is larger; QCA is smaller) probably results from the
presence of angiographically undetected eccentric disease of the
reference segment. Stenting usually results in a concentric residual
lumen, thus eliminating the differences between QCU and QCA estimates.
This study demonstrated that the accuracy and precision of QCA and QCU
in vitro are not related to the amount of stent x-ray opacity or to
stent design either immediately after deployment or with simulated
in-stent restenosis. In vivo, QCA and QCU of stented segments
produce nearly identical quantitative measurements.
Study Limitations
Conclusions
Received January 29, 1998;
revision received May 28, 1998;
accepted June 5, 1998.
2.
Ozaki Y, Keane D, Nobuyoshi M, Hamasaki N, Popma JJ,
Serruys PW. Coronary lumen at six-month follow-up of a new
radiopaque Cordis tantalum stent using quantitative angiography and
intracoronary ultrasound. Am J Cardiol. 1995;76:11351143.[Medline]
[Order article via Infotrieve]
3.
Keane D, Schuurbiers J, Slager CJ, Ozaki Y, den Boer
A, Bruining N, Serruys PW. Comparative quantitative mechanical,
radiographic, and angiographic analysis of eight
coronary stent designs. In: Coronary Stenting: A
Quantitative Angiographic and Clinical Evaluation. Netherlands;
David Keane; 1995:243271.
4.
Wenguang L, Gussenhoven WJ, Zhong Y, The SH, Di Mario
C, Madretsma S, van Egmond F, de Feyter P, Pieterman H, van Urk HL.
Validation of quantitative analysis of intravascular ultrasound
images. Int J Card Imaging. 1991;6:247253.[Medline]
[Order article via Infotrieve]
5.
Coy KM, Park JC, Fishbein MC, Laas T, Diamond GA,
Adler L, Maurer G, Siegel RJ. In vitro validation of
three-dimensional intravascular ultrasound for the evaluation of
arterial injury after balloon angioplasty. J Am
Coll Cardiol. 1992;20:692700.[Abstract]
6.
Leung WH, Sanders W, Alderman EL. Coronary
artery quantitation and data management system for paired
cineangiograms. Cathet Cardiovasc Diagn. 1991;24:121134.[Medline]
[Order article via Infotrieve]
7.
Leung WH, Demopulos PA, Alderman EL, Sanders W,
Stadius ML. Evaluation of catheters and metallic catheter markers as
calibration standard for measurement of coronary dimension.
Cathet Cardiovasc Diagn. 1990;21:148153.[Medline]
[Order article via Infotrieve]
8.
Leung WH, Stadius ML, Alderman EL. Determinants of
normal coronary artery dimensions in humans.
Circulation. 1991;84:22942306.
9.
Beauman GJ, Reiber JH, Koning G, Vogel RA. Comparisons
of angiographic core laboratory analyses of phantom and
clinical images: interlaboratory variability. Cathet Cardiovasc
Diagn. 1996;37:2431.[Medline]
[Order article via Infotrieve]
10.
Van der Zwet PM, Reiber JH. A new approach for the
quantification of complex lesion morphology: the gradient field
transform; basic principles and validation results. J Am
Coll Cardiol. 1994;24:216224.[Abstract]
11.
Keane D, Haase J, Slager CJ, van Swijndregt EM, Lehmann
K, Ozaki Y, di Mario C, Kirkeeide R, Serruys PW. Comparative validation
of quantitative coronary angiography systems: results and
implications from a multicenter study using a standardized approach.
Circulation. 1995;91:21742183.
12.
Haase J, Escaned J, van Swijndregt EM, Ozaki Y,
Gronenschild E, Slager CJ, Serruys PW. Experimental validation of
geometric and densitometric coronary measurements on the new
generation Cardiovascular Angiography Analysis
System (CAAS II). Cathet Cardiovasc Diagn. 1993;30:104114.[Medline]
[Order article via Infotrieve]
13.
Reiber JHC, Von Land CD, Koning G, van der Zwet PMJ,
van Houdt RCM, Schalij MJ, Lesperance J. Comparison of accuracy
and precision of quantitative coronary arterial
analysis between cinefilm and digital systems. In: Reiber JHC,
Serruys PW, eds. Progress in Quantitative Coronary
Angiography. Netherlands: Kluwer Academic Publishers;
1994:6785.
14.
Van der Zwet PMJ, Pinto IMF, Serruys PW, Reiber JHC. A
new approach for the automated definition of the path lines in
digitized coronary angiograms. Int J Card
Imaging. 1990;5:7583.[Medline]
[Order article via Infotrieve]
15.
Gronenschild E, Janssen J, Tijdens F. CAASII. A second
generation system for off-line and on-line quantitative
coronary angiography. Cathet Cardiovasc Diagn. 1994;33:6175.[Medline]
[Order article via Infotrieve]
16.
Reiber JHC, Schiemank LR, van der Zwet, PMJ, Goedhart
B, Koning G, Lammertsma M, Danse M, Gerbrands JJ, Schalij MJ. Bruschke
AVG. State of the art in quantitative coronary angiography as
of 1996. In: Reiber JHC, van der Wall EE, eds.
Cardiovascular Imaging. Boston, Mass: Kluwer
Academic Publishers; 1996:3956.Palmaz-Schatz, Wiktor, Multilink,
NIR, and InStent stents were deployed in precision cast phantoms.
Central lumens of 2.0 mm were created. There was no difference
between "true" diameters of these lumens by both quantitative
coronary angiography (QCA) and quantitative poststenting
ultrasonic (QCU) measurements. QCA systematic error (SE) was 0.01 to
0.14 mm, and random error (RE) was 0.03 to 0.14 mm. QCU SE
was 0.05 to 0.11 mm, and RE was 0.01 to 0.07 mm. In 50
stented segments, in patients, Palmaz-Schatz and Wiktor stents revealed
no difference in QCA or QCU diameter. QCA can be used as an accurate
method of poststent assessment.
© 1998 American Heart Association, Inc.
Clinical Investigation and Reports
Coronary Stents
In Vitro Aspects of an Angiographic and Ultrasound Quantification With In Vivo Correlation
![]()
Abstract
Top
Abstract
Introduction
Methods
Results
Discussion
References
BackgroundThe validity of
quantitative coronary angiography (QCA) after stent placement
has been questioned because the optical density of a metallic stent,
added to the density of a contrast-filled lumen, could affect
border definition.
Key Words: stents angiography ultrasonics
![]()
Introduction
Top
Abstract
Introduction
Methods
Results
Discussion
References
The use of intracoronary stents during the past
few years has raised serious doubts regarding the validity of
quantitative coronary angiography (QCA) after stent placement.
Many authors have been concerned that the optical density of a metallic
stent, added to the optical density of the contrast-filled lumen,
adversely affects border definition. It is commonly believed that this
limitation is more pronounced for the highly opaque Wiktor (Medtronic,
tantalum) and moderately opaque Micro (AVE, 316 stainless steel)
stents. Moreover, it was reported that determinations made with certain
QCA systems on the deployed Palmaz-Schatz (PS) stents in a Plexiglas
lumen of known diameter yielded measurements of luminal diameters that
were greater than those obtained in the same lumen before
stenting.1 Ozaki et al2
also reported a significant decrease in QCA accuracy and precision in
the presence of metallic stents.3 Hence, it is
unclear to what extent stent opacity interferes with the angiographic
quantification of in-stent restenosis. To some degree, these
same questions surround intravascular ultrasound (IVUS)
interpretation. There are very few validation studies of
quantitative4 5 poststenting ultrasonic
measurements (QCU).2
![]()
Methods
Top
Abstract
Introduction
Methods
Results
Discussion
References
Phantom Stage 1: Immediate Poststenting Model
There were 3 stages in the phantom study. In stage 1, 2 phantoms
were made from blocks of transparent casting resin that measured
15x6x1.6 cm. Each had a set of 6 lumens cast with high precision over
a metal rod of exact dimensions. The diameter of the lumen was 3
mm in phantom 1 and 4 mm in phantom 2.
In Stage 2, the phantom lumens were rinsed clean, carefully
dried, and filled with casting resin. Before the casting resin was
solidified, another high-precision rod, 2 mm in diameter, was used
to cast another 2.0-mm-diameter lumen in the geometric center of the
original lumen to simulate a comparable amount of in-stent intimal
proliferation (Figure 1
). Angiographic
and IVUS imaging was then performed, followed by QCA and QCU.
"True" luminal diameter was confirmed by use of calibrated
stainless steel rods of increasing size.

View larger version (76K):
[in a new window]
Figure 1. Magnified portion of phantom stage 3. Phantoms
were 4.0-mm Wiktor stents with "restenotic" lumen diameter
of 2.0, 2.5, and 3.0 mm.
Stage 3 consisted of simulating the different amounts of
intrastent proliferation for a highly opaque versus a low-opacity
stent. Two phantoms with five 4.0-mm lumens were created. Four 4.0-mm
Medtronic Wiktor stents were deployed into these lumens in 1 phantom,
and four 4.0-mm J&J PS stents were deployed in the second phantom. The
fifth channel was left as control. After deployment, all stented lumens
were filled with casting resin, and 1.5-, 2.0-, 2.5-, and 3.0-mm lumens
were precision drilled into the geometric center of the original lumens
to simulate various amounts of in-stent growth. Angiographic and IVUS
imaging were performed, followed by QCA and QCU.
Coronary angiograms in study patients were obtained
after the deployment of 25 PS stents and 25 Wiktor stents. Manual IVUS
pullbacks were performed to ascertain adequate stent apposition and
expansion. To standardize QCA and IVUS measurements, the angiographic
frame selected for QCA with minimal foreshortening of the vessel was
captured and printed as a hard copy. During IVUS measurements, this
hard copy was used as a road map. The QCU operator (Y.K.) marked the
exact position of IVUS cross-sectional measurements on this
angiographic image. After QCU, QCA was performed. The method of
obtaining QCA measurements was modified specifically for this study:
Instead of averaging diameters into mean diameter and extrapolating
them into reference diameter, we obtained QCA diameter values in the
points at which QCU cross-sectional measurements were made. Four
measurements were obtained2 within the stent, 1 proximal to the
stent, and 1 distal to the stentand used as reference
measurements.
Statistical analysis was performed by use of SPSS for
Windows (SPSS Inc) with paired and unpaired Student's t
tests. Continuous variables are expressed as mean±SD. Correlation
and linear regression analyses were also performed.
![]()
Results
Top
Abstract
Introduction
Methods
Results
Discussion
References
Phantom Stage 1: Immediate Poststenting Model
There was no difference between the control lumen measurements (no
stent) and any stented lumen with both QCA and QCU (Table 1
) by nonpaired statistics.
Systematic error for QCA varied from 0.01 mm for the Wiktor stents
to 0.06 mm for the InStent and Multilink stents. Random error was
least for the InStent (0.06 mm) and most for the control channel
(0.1 mm). QCU systematic error was least for the control channel
(-0.08 mm) and most for the Multilink and NIR (0.19 mm)
stents. QCU random error was smallest for the Wiktor, InStent, and
control channel and highest for the PS stents. There was no difference
in accuracy or precision of QCA and QCU of stented versus control
lumens. Paired statistics demonstrated significantly smaller lumens for
the Multilink, NIR, and InStent stents when measured by IVUS compared
with QCA. On the other hand, an estimate of the control channel
diameter was higher with QCU. Plots of absolute differences between
true and measured values are presented in Figure 2
.
View this table:
[in a new window]
Table 1. QCU and QCA Comparison With Immediate Poststent
Model

View larger version (41K):
[in a new window]
Figure 2. Comparison between QCU and QCA for various stents
and control channels (stage 1: immediately after stent
deployment).
The simulation of moderate "restenosis" (Table 2
) with 1.78- to 1.8-mm lumens within
3.0-mm (40% stenosis) and 4.0-mm (55% stenosis)
channels demonstrated no statistically significant differences between
the true lumen and its estimates by QCA and QCU. The highest QCA
systematic error (-0.14 mm) was obtained for the PS stents; the
lowest (0.01 mm), for the Wiktor stents. The highest QCU
systematic error value was obtained for the PS and InStent stents
(-0.11 mm); the smallest, for the control channel, Wiktor, and
Multilink (-0.03, -0.09, and -0.08 mm, respectively). QCA
random error was comparable to immediate postdeployment measurements.
The highest values were obtained for the InStent and the smallest for
the PS and Multilink stents. IVUS random error was also highest for NIR
and InStent and smallest for the PS, Wiktor, and Multilink stents.
There was no difference in in-stent measurements between QCA and QCU.
The plots of absolute differences between the true and measured values
(Figure 3
) demonstrate the absence of
significant differences between the true values and the QCA or QCU
estimates. There was no statistically significant difference between
QCA and QCU lumen estimates.
View this table:
[in a new window]
Table 2. QCU and QCA Comparison With Moderate Poststent
Restenosis
Model

View larger version (41K):
[in a new window]
Figure 3. Comparison between QCU and QCA for various stents
and control channels (stage 2: model of moderate intrastent
restenosis (2.0-mm residual lumen).
There was no statistically significant difference between the true
size of residual lumens and QCA and QCU estimates (Tables 3
and 4
)
for both Wiktor and PS stents. QCA systematic error was 0.08 mm
for Wiktor and 0.13 mm for PS stents, whereas QCU systematic
error was 0.09 mm for Wiktor and 0.14 mm for PS stents.
QCA random error was 0.08 mm for both Wiktor and PS stents. QCU
random error was 0.05 mm for Wiktor and 0.09 mm for PS
stents. Correlation coefficients between true lumen diameter and QCA or
QCU estimate and between QCA and QCU lumen estimates were 0.99 for both
stents. The plots of absolute differences between true and measured
lumen diameters (Figures 4
and 5
) demonstrate close correlation between
the 2 methods. QCA and QCU measurements of 1.5- to 2.5-mm residual
lumens resulted in some overestimation (0.1 to 0.3 mm) of luminal
size.
View this table:
[in a new window]
Table 3. QCA and QCU Comparison for 4.0-mm Wiktor Stents With
Model of Variable Amount of
Restenosis
View this table:
[in a new window]
Table 4. QCA and QCU Comparison for 4.0-mm PS Stents With
Model of Variable Amount of
Restenosis

View larger version (24K):
[in a new window]
Figure 4. Comparison between QCU and QCA for the model of
variable restenosis after 4.0-mm Wiktor stent deployment
(phantom stage 3).

View larger version (23K):
[in a new window]
Figure 5. Comparison between QCU and QCA for the model of
variable restenosis after 4.0-mm PS stent deployment
(phantom stage 3).
Forty-six measurements of stented segments were performed in both
the PS and Wiktor groups (2 measurements per stent). Forty-two and 40
reference segments, respectively, were measured on both sides of
stented segments (Table 5
). In the ostial
or very proximal lesions, only 1 reference segment was measured. There
was no difference between QCU and QCA measurements of the reference
diameters between the PS and Wiktor groups by nonpaired statistics. QCU
and QCA diameters of the stented segment were significantly larger for
the Wiktor group. For the reference diameters in both the Wiktor and PS
groups, QCU measurements provided larger values than QCA. For the
stented segments in both groups, there was no difference between QCA
and QCU diameter values. There was also a close linear correlation
between QCU and QCA for the PS and Wiktor groups (r=0.81 to
0.7, respectively). Figure 6
demonstrates
approximately the same relationships between QCA and QCU for both
groups.
View this table:
[in a new window]
Table 5. QCA and QCU Measurements: Comparison Between PS and
Wiktor Stents in
Patients

View larger version (32K):
[in a new window]
Figure 6. Clinical QCA and QCU comparisons for Wiktor and PS
stents. D indicates diameter.
![]()
Discussion
Top
Abstract
Introduction
Methods
Results
Discussion
References
Immediate postdeployment measurements in vitro (phantom stage 1)
demonstrated that there was no difference between the measurement of
control or any stented lumen by either QCA or QCU. For QCA, this means
that even the addition of the highly opaque Wiktor stent did not
influence border definition. Previously reported poststenting
"increase" in the lumen of a similar phantom1
can be related to a difference in the border detection algorithm. Both
systematic and random error values for QCA and QCU are excellent, and
the detected variations are minor. There was significantly smaller
lumen for the Multilink, NIR, and InStent stents when measured by IVUS
compared with QCA. An estimate of the control channel diameter was
higher with QCU. We believe that the differences between QCU and QCA
measurements of the stented lumen immediately after stent deployment
reflect the fact that QCA measures the outer boundaries of the
contrast-filled channel (Figure 7
),
whereas QCU traces the inner surface of the stent. In vivo, stent
struts are ideally embedded into the vessel wall, causing intrastent
lumen to equal vessel lumen. In the rigid phantom channel, the stent
lies within the lumen; therefore, QCU cross-sectional measurements of
the stented lumen are somewhat smaller than the actual lumen diameter
of the cast model. In PS and Wiktor stents, widely spaced struts
allowed QCU tracing of portions of the channel wall as well as metal,
while in Multilink, NIR, and InStent stents, the closely spaced struts
prevented wall tracing, thus creating a significant difference in the
luminal diameter between QCU and QCA (Figures 7
and 8
). Of course, this difference between
stent models could disappear if the operator measures only the distance
between opposing leading stent edges. However, this is not possible
because of variance in strut spacing and the nature of computerized
planimetry.

View larger version (63K):
[in a new window]
Figure 7. QCA and QCU measurement points immediately after
stent deployment. QCA applies to boundaries of contrast-filled lumen;
QCU measures either mixed intraluminal or intrastent diameters (B) or
exclusively intrastent diameters (C), depending on spacing of struts.
In vivo stent struts are embedded in vessel wall (A), and there is no
difference between intraluminal and intrastent diameters.

View larger version (180K):
[in a new window]
Figure 8. IVUS images of different stents. Top left
photograph was taken immediately after deployment of PS stent (stage
1), with superimposed tracing of vessel lumen (bottom left). Because of
the wide spacing of struts, portions of luminal wall also are traced.
Close spacing of the NIR struts (right top and bottom) prevents
operator from tracing actual lumen.
). The results of the phantom validation
of the newer and promising gradient field transform function for the
poststent coronary analysis have not been published
yet.16 The fact that there was no difference
between QCA and QCU diameters supports our explanation for the stage 1
discordance.

View larger version (98K):
[in a new window]
Figure 9. Examples of edge detection (phantom stage 2). A,
Control lumen; B, phantom model of moderate restenosis within
Wiktor stent.
shows the close agreement
between QCU and QCA, except in the last channel with a residual lumen
of 3.0 mm. This last channel represented the smallest
difference between the stent and the lumen, ie, very mild
recurrence. In these 3 measurements, QCA tended to
underestimate channel diameter. This finding is probably related to the
short distance between the metal stent and its lumen (<0.5 mm).
We conclude therefore that the only instance in which QCA measurements
can be misleading occurs when there is mild in-stent
restenosis. This observation is applicable only for the highly
opaque Wiktor stent. With PS stents, there was no QCA underestimation
for the 3.0-mm phantom lumen. This observation is similar to that
reported by Ozaki et al,2 implying that in the
poststenting QCA measurement, the reference diameter should never be
selected within a stented region. The systematic error values were
slightly higher for the PS than Wiktor stents. We do not have an
explanation for this result, but it suggests that factors other than
radiopacity could be involved.
A main limitation of this study is the predominantly in vitro
character of the data, with limited in vivo validation
represented only by acute poststent imaging. The absence of
the perfect method to quantify the extent of in-stent growth with
absolute precision is the cause of this criticism. Our in vivo
validation was undertaken chiefly to compare the lumen quantification
within the most visible (Wiktor) and least visible (PS) stents.
QCU lumen measurements remain quantitatively robust for the
assessment of the coronary lumen after stenting. QCA can be
used as a sensitive and accurate method of poststent lumen assessment,
except when a very mild recurrence is measured within a highly
opaque stent. In that instance, QCA may underestimate luminal
diameter.
![]()
Acknowledgments
We would like to thank David F. Profitt, MSEE, for his help in
the preparation of the phantoms.
![]()
References
Top
Abstract
Introduction
Methods
Results
Discussion
References
1.
Fish RP, Das TS. QCA overestimates stented lumens:
a source of artifact in the late loss index of coronary
stenting. Circulation. 1997;92(suppl I):I-599.
Abstract.
This article has been cited by other articles:
![]() |
J.u. Pache, A. Kastrati, J. Mehilli, H. Schuhlen, F. Dotzer, J.o. Hausleiter, M. Fleckenstein, F.-J. Neumann, U. Sattelberger, C. Schmitt, et al. Intracoronary stenting and angiographic results: strut thickness effect on restenosis outcome (ISAR-STEREO-2) trial J. Am. Coll. Cardiol., April 16, 2003; 41(8): 1283 - 1288. [Abstract] [Full Text] [PDF] |
||||
![]() |
N. Funabashi, Y. Kobayashi, M. Perlroth, and G. D. Rubin Coronary Artery: Quantitative Evaluation of Normal Diameter Determined with Electron-Beam CT Compared with Cine Coronary Angiography--Initial Experience Radiology, January 1, 2003; 226(1): 263 - 271. [Abstract] [Full Text] [PDF] |
||||
![]() |
A. Kastrati, A. Schomig, J. Dirschinger, J. Mehilli, N. von Welser, J. Pache, H. Schuhlen, T. Schilling, C. Schmitt, and F.-J. Neumann Increased Risk of Restenosis After Placement of Gold-Coated Stents : Results of a Randomized Trial Comparing Gold-Coated With Uncoated Steel Stents in Patients With Coronary Artery Disease Circulation, May 30, 2000; 101(21): 2478 - 2483. [Abstract] [Full Text] [PDF] |
||||
![]() |
C. E. Chambers, S. T Riebel, and M. Kozak Interventional Cardiology: Advances in Percutaneous Techniques for the Treatment of Cardiac Disease Seminars in Cardiothoracic and Vascular Anesthesia, July 1, 1999; 3(2): 109 - 125. [Abstract] [PDF] |
||||
| |||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||
|
Circulation Home | Subscriptions | Archives | Feedback | Authors | Help | AHA Journals Home | Search Copyright © 1998 American Heart Association, Inc. All rights reserved. Unauthorized use prohibited. |